IJCS | Volume 31, Nº5, September / October 2018

491 Pivatto Júnior et al. SAMe-TT 2 R 2 score forVTE patients? Int J Cardiovasc Sci. 2018;31(5)483-491 Original Article This is an open-access article distributed under the terms of the Creative Commons Attribution License 18. Gallego P, Roldán V, Marin F, Gálvez J, Valdés M, Vicente V, et al. SAMe- TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Am J Med. 2014;127(11):1083-8. 19. Chan PH, Hai JJ, Chan EW, Li WH, Tse HF, Wong IC, et al. Use of the SAMe-TT2R2 score to predict good anticoagulation control withwarfarin in Chinese patients with atrial fibrillation: relationship to ischemic stroke incidence. PLoS One. 2016;11(3):e0150674. 20. Abumuaileq RR, Abu-Assi E, Raposeiras-Roubin S, López-López A, Redondo-Diéguez A, Álvarez-Iglesias D, et al. Evaluation of SAMe- TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists. Europace. 2015;17(5):711-7. 21. Lip GY, Haguenoer K, Saint-Etienne C, Fauchier L. Relationship of the SAMe-TT2R2 score to poor-quality anticoagulation, stroke, clinically relevant bleeding, andmortality in patients with atrial fibrillation. Chest. 2014;146(3):719-26. 22. Poli D, Antonucci E, Testa S, Lip GY. A prospective validation of the SAME-TT2R2 score: how to identify atrial fibrillation patients who will have good anticoagulation control on warfarin. Intern Emerg Med. 2014;9(4):443-7. 23. Roldán V, Cancio S, Gálvez J, Valdés M, Vicente V, Marín F, et al. The SAMe-TT2R2 score predicts poor anticoagulation control in AF patients: a prospective 'real-world' inception cohort study. Am J Med. 2015;128(11):1237-43. 24. Ruiz-Ortiz M, Bertomeu V, Cequier Á, Marín F, Anguita M. Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Thromb Haemost. 2015;114(4):695-701. 25. Proietti M, Lane DA, Lip GY. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: observations from the SPORTIF trials. Int J Cardiol. 2016 Aug 1;216:168-72. 26. Martinez C, Katholing A, Reitbrock S, Lip GY, Freedman B. SAMeTT2R2 scores predict stroke risk after initiation of vitamin K antagonist therapy for atrial fibrillation: a real-world practice study (abstract). Circulation 2014;130(Suppl 2):A19565. 27. Gorzelak-Pabi ś P, Zyzak S, Krewko Ł, Broncel M. Assessment of the mean time in the therapeutic INR range and the SAMe-TT2R2 score in patients with atrial fibrillation and cognitive impairment. Pol ArchMed Wewn. 2016;126(7-8):494-501. 28. Lobos-Bejarano JM, Barrios V, Polo-García J, Escobar C, Vargas-Ortega D, Marín-Montañés N, et al; PAULA Study Team. Evaluation of SAMe-TT2R2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in Spain. Curr Med Res Opin. 2016;32(7):1201-7. 29. Bernaitis N, Ching CK, Chen L, Hon JS, Teo SC, Davey AK, et al. The sex, age, medical history, treatment, tobacco use, race risk (SAMe-TT2R2) score predicts warfarin control in a Singaporean population. J Stroke Cerebrovasc Dis. 2017;26(1):64-9. 30. Rose AJ, Sharman JP, Ozonoff A, Henault LE, Hylek EM. Effectiveness of warfarinamongpatientswithcancer.JGenInternMed.2007;22(7):997-1002. 31. Søreide K. Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol. 2009;62(1):1-5. 32. Hajian-Tilaki K. Receiver Operating Characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4(2):627-35.